世界の糖尿病用非インスリン療法市場

QYResearchが発行した調査報告書(DATA909X12070)
◆英語タイトル:Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2019
◆商品コード:DATA909X12070
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月20日
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥483,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥724,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥966,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、糖尿病用非インスリン療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アルファグルコシダーゼ阻害剤、アミリンアゴニスト、ビグアニド、ジペプチジルペプチダーゼ-4(DPP4)阻害剤、グリニド/メグリチニド、GLP-1アナログ/ GLP-1アゴニスト、ナトリウム-グルコース共輸送体2(SGLT2)阻害剤、スルフォニル尿素、チアゾリジンジオン、その他に、用途別には、病院薬局、小売薬局、オンライン薬局、その他にセグメント区分し、糖尿病用非インスリン療法の世界市場を分析しました。


・エグゼクティブ・サマリー
・糖尿病用非インスリン療法の世界市場概要
・糖尿病用非インスリン療法の製造コスト構成分析
・糖尿病用非インスリン療法の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・糖尿病用非インスリン療法の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・糖尿病用非インスリン療法のセグメント分析(種類別)
(アルファグルコシダーゼ阻害剤、アミリンアゴニスト、ビグアニド、ジペプチジルペプチダーゼ-4(DPP4)阻害剤、グリニド/メグリチニド、GLP-1アナログ/ GLP-1アゴニスト、ナトリウム-グルコース共輸送体2(SGLT2)阻害剤、スルフォニル尿素、チアゾリジンジオン、その他)
・糖尿病用非インスリン療法のセグメント分析(用途別)
(病院薬局、小売薬局、オンライン薬局、その他)
・糖尿病用非インスリン療法の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(GSK、Eli Lilly、Sumitomo Dainippon Pharma、Intarcia Therapeutics、Servier、Jiangsu Hansoh Pharmaceutical、Novo Nordisk、Emisphere、Uni-Bio Science Group、Takeda、3SBio、Merck、Dong-A Pharmaceutical、Luye Pharma Group、Eurofarma、Geropharm、Alkem Labs、SatRx、Pfizer、Jiangsu Hengrui Medicine、)
・糖尿病用非インスリン療法の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Non-Insulin Therapies for Diabetes market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Non-Insulin Therapies for Diabetes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Insulin Therapies for Diabetes market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Non-Insulin Therapies for Diabetes in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Non-Insulin Therapies for Diabetes manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Alpha-glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides / Meglitinides
GLP-1 Analogs / GLP-1 Agonists
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Sulfonylureas
Thiazolidinediones
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Non-Insulin Therapies for Diabetes
1.1 Definition of Non-Insulin Therapies for Diabetes
1.2 Non-Insulin Therapies for Diabetes Segment by Type
1.2.1 Global Non-Insulin Therapies for Diabetes Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Alpha-glucosidase Inhibitors
1.2.3 Amylin Agonists
1.2.4 Biguanides
1.2.5 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.6 Glinides / Meglitinides
1.2.7 GLP-1 Analogs / GLP-1 Agonists
1.2.8 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
1.2.9 Sulfonylureas
1.2.10 Thiazolidinediones
1.2.11 Others
1.3 Non-Insulin Therapies for Diabetes Segment by Applications
1.3.1 Global Non-Insulin Therapies for Diabetes Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Non-Insulin Therapies for Diabetes Overall Market
1.4.1 Global Non-Insulin Therapies for Diabetes Revenue (2014-2025)
1.4.2 Global Non-Insulin Therapies for Diabetes Production (2014-2025)
1.4.3 North America Non-Insulin Therapies for Diabetes Status and Prospect (2014-2025)
1.4.4 Europe Non-Insulin Therapies for Diabetes Status and Prospect (2014-2025)
1.4.5 China Non-Insulin Therapies for Diabetes Status and Prospect (2014-2025)
1.4.6 Japan Non-Insulin Therapies for Diabetes Status and Prospect (2014-2025)
1.4.7 Southeast Asia Non-Insulin Therapies for Diabetes Status and Prospect (2014-2025)
1.4.8 India Non-Insulin Therapies for Diabetes Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes
2.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
2.4 Industry Chain Structure of Non-Insulin Therapies for Diabetes

3 Development and Manufacturing Plants Analysis of Non-Insulin Therapies for Diabetes
3.1 Capacity and Commercial Production Date
3.2 Global Non-Insulin Therapies for Diabetes Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Non-Insulin Therapies for Diabetes
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Non-Insulin Therapies for Diabetes Production and Capacity Analysis
4.2 Non-Insulin Therapies for Diabetes Revenue Analysis
4.3 Non-Insulin Therapies for Diabetes Price Analysis
4.4 Market Concentration Degree

5 Non-Insulin Therapies for Diabetes Regional Market Analysis
5.1 Non-Insulin Therapies for Diabetes Production by Regions
5.1.1 Global Non-Insulin Therapies for Diabetes Production by Regions
5.1.2 Global Non-Insulin Therapies for Diabetes Revenue by Regions
5.2 Non-Insulin Therapies for Diabetes Consumption by Regions
5.3 North America Non-Insulin Therapies for Diabetes Market Analysis
5.3.1 North America Non-Insulin Therapies for Diabetes Production
5.3.2 North America Non-Insulin Therapies for Diabetes Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Non-Insulin Therapies for Diabetes Import and Export
5.4 Europe Non-Insulin Therapies for Diabetes Market Analysis
5.4.1 Europe Non-Insulin Therapies for Diabetes Production
5.4.2 Europe Non-Insulin Therapies for Diabetes Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Non-Insulin Therapies for Diabetes Import and Export
5.5 China Non-Insulin Therapies for Diabetes Market Analysis
5.5.1 China Non-Insulin Therapies for Diabetes Production
5.5.2 China Non-Insulin Therapies for Diabetes Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Non-Insulin Therapies for Diabetes Import and Export
5.6 Japan Non-Insulin Therapies for Diabetes Market Analysis
5.6.1 Japan Non-Insulin Therapies for Diabetes Production
5.6.2 Japan Non-Insulin Therapies for Diabetes Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Non-Insulin Therapies for Diabetes Import and Export
5.7 Southeast Asia Non-Insulin Therapies for Diabetes Market Analysis
5.7.1 Southeast Asia Non-Insulin Therapies for Diabetes Production
5.7.2 Southeast Asia Non-Insulin Therapies for Diabetes Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Non-Insulin Therapies for Diabetes Import and Export
5.8 India Non-Insulin Therapies for Diabetes Market Analysis
5.8.1 India Non-Insulin Therapies for Diabetes Production
5.8.2 India Non-Insulin Therapies for Diabetes Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Non-Insulin Therapies for Diabetes Import and Export

6 Non-Insulin Therapies for Diabetes Segment Market Analysis (by Type)
6.1 Global Non-Insulin Therapies for Diabetes Production by Type
6.2 Global Non-Insulin Therapies for Diabetes Revenue by Type
6.3 Non-Insulin Therapies for Diabetes Price by Type

7 Non-Insulin Therapies for Diabetes Segment Market Analysis (by Application)
7.1 Global Non-Insulin Therapies for Diabetes Consumption by Application
7.2 Global Non-Insulin Therapies for Diabetes Consumption Market Share by Application (2014-2019)

8 Non-Insulin Therapies for Diabetes Major Manufacturers Analysis
8.1 GSK
8.1.1 GSK Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.1.2 GSK Product Introduction, Application and Specification
8.1.3 GSK Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sumitomo Dainippon Pharma
8.3.1 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.3.2 Sumitomo Dainippon Pharma Product Introduction, Application and Specification
8.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Intarcia Therapeutics
8.4.1 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.4.2 Intarcia Therapeutics Product Introduction, Application and Specification
8.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Servier
8.5.1 Servier Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.5.2 Servier Product Introduction, Application and Specification
8.5.3 Servier Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Jiangsu Hansoh Pharmaceutical
8.6.1 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.6.2 Jiangsu Hansoh Pharmaceutical Product Introduction, Application and Specification
8.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novo Nordisk
8.7.1 Novo Nordisk Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.7.2 Novo Nordisk Product Introduction, Application and Specification
8.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Emisphere
8.8.1 Emisphere Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.8.2 Emisphere Product Introduction, Application and Specification
8.8.3 Emisphere Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Uni-Bio Science Group
8.9.1 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.9.2 Uni-Bio Science Group Product Introduction, Application and Specification
8.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Takeda
8.10.1 Takeda Non-Insulin Therapies for Diabetes Production Sites and Area Served
8.10.2 Takeda Product Introduction, Application and Specification
8.10.3 Takeda Non-Insulin Therapies for Diabetes Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 3SBio
8.12 Merck
8.13 Dong-A Pharmaceutical
8.14 Luye Pharma Group
8.15 Eurofarma
8.16 Geropharm
8.17 Alkem Labs
8.18 SatRx
8.19 Pfizer
8.20 Jiangsu Hengrui Medicine

9 Development Trend of Analysis of Non-Insulin Therapies for Diabetes Market
9.1 Global Non-Insulin Therapies for Diabetes Market Trend Analysis
9.1.1 Global Non-Insulin Therapies for Diabetes Market Size (Volume and Value) Forecast 2019-2025
9.2 Non-Insulin Therapies for Diabetes Regional Market Trend
9.2.1 North America Non-Insulin Therapies for Diabetes Forecast 2019-2025
9.2.2 Europe Non-Insulin Therapies for Diabetes Forecast 2019-2025
9.2.3 China Non-Insulin Therapies for Diabetes Forecast 2019-2025
9.2.4 Japan Non-Insulin Therapies for Diabetes Forecast 2019-2025
9.2.5 Southeast Asia Non-Insulin Therapies for Diabetes Forecast 2019-2025
9.2.6 India Non-Insulin Therapies for Diabetes Forecast 2019-2025
9.3 Non-Insulin Therapies for Diabetes Market Trend (Product Type)
9.4 Non-Insulin Therapies for Diabetes Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Non-Insulin Therapies for Diabetes Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Non-Insulin Therapies for Diabetes
Table Global Non-Insulin Therapies for Diabetes Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Non-Insulin Therapies for Diabetes Production Market Share by Types in 2018
Figure Alpha-glucosidase Inhibitors Product Picture
Figure Amylin Agonists Product Picture
Figure Biguanides Product Picture
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Product Picture
Figure Glinides / Meglitinides Product Picture
Figure GLP-1 Analogs / GLP-1 Agonists Product Picture
Figure Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Product Picture
Figure Sulfonylureas Product Picture
Figure Thiazolidinediones Product Picture
Figure Others Product Picture
Table Global Non-Insulin Therapies for Diabetes Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Retail Pharmacies
Figure Online Pharmacy
Figure Others
Figure Global Non-Insulin Therapies for Diabetes Revenue (Million USD) (2014-2025)
Figure Global Non-Insulin Therapies for Diabetes Production (K Units) (2014-2025)
Figure North America Non-Insulin Therapies for Diabetes Market Size (Million USD) (2014-2025)
Figure Europe Non-Insulin Therapies for Diabetes Market Size (Million USD) (2014-2025)
Figure China Non-Insulin Therapies for Diabetes Market Size (Million USD) (2014-2025)
Figure Japan Non-Insulin Therapies for Diabetes Market Size (Million USD) (2014-2025)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Market Size (Million USD) (2014-2025)
Figure India Non-Insulin Therapies for Diabetes Market Size (Million USD) (2014-2025)
Table Non-Insulin Therapies for Diabetes Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes in 2018
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Industry Chain Structure of Non-Insulin Therapies for Diabetes
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Non-Insulin Therapies for Diabetes Manufacturing Plants Distribution
Table Non-Insulin Therapies for Diabetes Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Non-Insulin Therapies for Diabetes Capacity (K Units) of Major Manufacturers (2014-2019)
Table Non-Insulin Therapies for Diabetes Production (K Units) of Major Manufacturers (2014-2019)
Table Non-Insulin Therapies for Diabetes Production Market Share of Major Manufacturers (2014-2019)
Figure Non-Insulin Therapies for Diabetes Production Share by Manufacturers in 2018
Table Non-Insulin Therapies for Diabetes Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Non-Insulin Therapies for Diabetes Revenue Market Share of Major Manufacturers (2014-2019)
Figure Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers in 2018
Table Non-Insulin Therapies for Diabetes Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Non-Insulin Therapies for Diabetes Production by Regions 2014-2019 (K Units)
Table Global Non-Insulin Therapies for Diabetes Production Market Share by Regions 2014-2019
Figure Global Non-Insulin Therapies for Diabetes Production Market Share by Regions in 2018
Table Global Non-Insulin Therapies for Diabetes Revenue by Regions 2014-2019 (Million USD)
Table Global Non-Insulin Therapies for Diabetes Revenue Market Share by Regions 2014-2019
Figure Global Non-Insulin Therapies for Diabetes Revenue Market Share by Regions in 2018
Table Global Non-Insulin Therapies for Diabetes Consumption by Regions 2014-2019 (K Units)
Table Global Non-Insulin Therapies for Diabetes Consumption Market Share by Regions 2014-2019
Figure North America Non-Insulin Therapies for Diabetes Production Growth Rate 2014-2019 (K Units)
Figure North America Non-Insulin Therapies for Diabetes Revenue Growth Rate 2014-2019 (Million USD)
Table North America Non-Insulin Therapies for Diabetes Production, Consumption Import and Export (K Units)
Figure Europe Non-Insulin Therapies for Diabetes Production Growth Rate 2014-2019 (K Units)
Figure Europe Non-Insulin Therapies for Diabetes Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Non-Insulin Therapies for Diabetes Production, Consumption Import and Export (K Units)
Figure China Non-Insulin Therapies for Diabetes Production Growth Rate 2014-2019 (K Units)
Figure China Non-Insulin Therapies for Diabetes Revenue Growth Rate 2014-2019 (Million USD)
Table China Non-Insulin Therapies for Diabetes Production, Consumption Import and Export (K Units)
Figure Japan Non-Insulin Therapies for Diabetes Production Growth Rate 2014-2019 (K Units)
Figure Japan Non-Insulin Therapies for Diabetes Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Non-Insulin Therapies for Diabetes Production, Consumption Import and Export (K Units)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption Import and Export (K Units)
Figure India Non-Insulin Therapies for Diabetes Production Growth Rate 2014-2019 (K Units)
Figure India Non-Insulin Therapies for Diabetes Revenue Growth Rate 2014-2019 (Million USD)
Table India Non-Insulin Therapies for Diabetes Production, Consumption Import and Export (K Units)
Figure Global Consumption Non-Insulin Therapies for Diabetes Market Share by Application (2014-2019)
Figure Global Value (Consumption) Non-Insulin Therapies for Diabetes Market Share by Application (2014-2019)
Table GSK Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table GSK Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table GSK Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table GSK Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure GSK Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table GSK Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Eli Lilly Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Eli Lilly Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Eli Lilly Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Eli Lilly Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Eli Lilly Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Eli Lilly Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Servier Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Servier Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Servier Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Servier Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Servier Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Servier Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Servier Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Novo Nordisk Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Novo Nordisk Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Novo Nordisk Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Novo Nordisk Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Novo Nordisk Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Novo Nordisk Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Emisphere Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Emisphere Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Emisphere Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Emisphere Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Emisphere Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Emisphere Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Emisphere Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table Takeda Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Takeda Non-Insulin Therapies for Diabetes Product Introduction, Application and Specification
Table Takeda Non-Insulin Therapies for Diabetes Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Non-Insulin Therapies for Diabetes Production Growth Rate (2014-2019)
Table Takeda Non-Insulin Therapies for Diabetes Production Market Share (2014-2019)
Figure Takeda Non-Insulin Therapies for Diabetes Revenue Market Share (2014-2019)
Table Takeda Non-Insulin Therapies for Diabetes Main Business and Markets Served
Table 3SBio Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Merck Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Dong-A Pharmaceutical Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Luye Pharma Group Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Eurofarma Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Geropharm Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Alkem Labs Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table SatRx Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Pfizer Non-Insulin Therapies for Diabetes Production Sites and Area Served
Table Jiangsu Hengrui Medicine Non-Insulin Therapies for Diabetes Production Sites and Area Served
Figure Global Non-Insulin Therapies for Diabetes Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Non-Insulin Therapies for Diabetes Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Non-Insulin Therapies for Diabetes Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Non-Insulin Therapies for Diabetes Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Non-Insulin Therapies for Diabetes Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Non-Insulin Therapies for Diabetes Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Non-Insulin Therapies for Diabetes Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Non-Insulin Therapies for Diabetes Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Non-Insulin Therapies for Diabetes Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Non-Insulin Therapies for Diabetes Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Non-Insulin Therapies for Diabetes Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Non-Insulin Therapies for Diabetes Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Non-Insulin Therapies for Diabetes Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Non-Insulin Therapies for Diabetes by Type (2019-2025)
Table Global Consumption (K Units) of Non-Insulin Therapies for Diabetes by Application (2019-2025)
Table Non-Insulin Therapies for Diabetes Distributors List
Table Non-Insulin Therapies for Diabetes Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

GSK、Eli Lilly、Sumitomo Dainippon Pharma、Intarcia Therapeutics、Servier、Jiangsu Hansoh Pharmaceutical、Novo Nordisk、Emisphere、Uni-Bio Science Group、Takeda、3SBio、Merck、Dong-A Pharmaceutical、Luye Pharma Group、Eurofarma、Geropharm、Alkem Labs、SatRx、Pfizer、Jiangsu Hengrui Medicine、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の糖尿病用非インスリン療法市場(Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。